Diffuse Systemic Sclerosis
6 clinical trials · Condition
◉ Watch Diffuse Systemic Sclerosis
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients (NCT04837131) | Michael M. Pham | 2021-04-28 |
| IL1-TRAP, Rilonacept, in Systemic Sclerosis (NCT01538719) | Boston University | 2011-12-01 |
| Fresolimumab In Systemic Sclerosis (NCT01284322) | Boston University | 2011-01-01 |
Track Diffuse Systemic Sclerosis automatically
Every clearance here is in the API, with alerts when new ones post.